why choose us

First received: March 21, 2023

Clinical Trial: Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Neurofibroma

Study Type: OBSERVATIONAL


Official Title: Non-interventional Study of Patients With Plexiform Neurofibromas and Neurofibromatosis Type I Starting Selumetinib in Russia

Brief Summary: The purpose of this study is to evaluate the effectiveness, safety of selumetinib and patient's parameters of symptomatic inoperable PN NF1 in real clinical practice in Russia

Read more